James George Robinson, Director, 10% Owner at NYMOX PHARMACEUTICAL CORP (NYMX), bought 80,000 shares at $0.45 ($37K) on 2023-04-25, disclosed to the SEC on 2023-06-26.
Open-market purchase of $37k NYMX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.45 | 40,000 | $18K | 48.9% |
| 2 | $0.47 | 40,000 | $19K | 51.1% |
| Total | $0.46 avg | 80,000 | $37K | 100% |
| Filing → |
| NYMX | BUY | 2021-04-27 | $83K | — | Filing → |
| NYMX | BUY | 2019-07-12 | $12K | — | Filing → |
| NYMX | BUY | 2019-07-10 | $11K | — | Filing → |